ATC Group: M01AC06 Meloxicam

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M01AC06 in the ATC hierarchy

Level Code Title
1 M Musculo-skeletal system
2 M01 Antiinflammatory and antirheumatic products
3 M01A Antiinflammatory and antirheumatic products, non-steroids
4 M01AC Oxicams
5 M01AC06 Meloxicam

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 15 mg
PAREN - Parenteral 15 mg
RECTAL - Rectal 15 mg

Active ingredients in M01AC06

Active Ingredient Description
Meloxicam

Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam family, with anti-inflammatory, analgesic and antipyretic properties. The anti-inflammatory activity of meloxicam has been proven in classical models of inflammation. As with other NSAID, its precise mechanism of action remains unknown. However, there is at least one common mode of action shared by all NSAID (including meloxicam): inhibition of the biosynthesis of prostaglandins, known inflammation mediators.

Related product monographs

Title Information Source Document Type  
FLAMARYX Tablet Health Products Regulatory Authority (ZA) MPI, Generic
MELCAM Tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
MELOREX Tablet Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
MELOX Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
MELOXICAM Orodispersible tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MOBIC Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
MOXICAM Tablet MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Austria (AT)

Finland (FI)

France (FR)

Germany (DE)

Ireland (IE)

Italy (IT)

Japan (JP)

Malta (MT)

Mexico (MX)

New Zealand (NZ)

Romania (RO)

Singapore (SG)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.